Velan Capital, L.P.

Jul 22, 2019

Velan Announces Progenics Pharmaceuticals Stockholders Support its Campaign for Change at Progenics' 2019 Annual Meeting

Jul 08, 2019

Velan Reminds Stockholders to Follow ISS' Recommendation by Voting "Against" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch

Jun 25, 2019

Velan Releases Presentation Reiterating the Facts and Setting The Record Straight for Progenics Pharmaceuticals' Stockholders

Jun 20, 2019

Velan Calls on Progenics Pharmaceuticals' Board to Back Up Recent Claims

Jun 17, 2019

Velan sets the Record Straight on Progenics Pharmaceuticals' Latest Misleading Statements

Jun 11, 2019

Velan Capital Sends Letter to Stockholders Calling Out Progenics Pharmaceuticals' Board for Unnecessarily Diluting Stockholders to Support Outsized And Undeserved Compensation

Jun 04, 2019

Velan Responds to Progenics Pharmaceuticals' Misleading Statements

May 13, 2019

Velan Implores for Improved Transparency and Real Change at Progenics Pharmaceuticals Following Q1 2019 Earnings Call

May 08, 2019

Velan Calls for Increased Transparency at Progenics Pharmaceuticals During Q1 Earnings Call

May 06, 2019

Velan Delivers Letter to the Board of Progenics Pharmaceuticals